Mitochondria-derived peptides in healthy ageing and therapy of age-related diseases.
Dabravolski. Siarhei A SA
Key Findings
- Humanin and related peptides have anti‑apoptotic, anti‑inflammatory, and cardioprotective actions.
- MDPs function as metabolic sensors and are connected to age‑related metabolic disorders and mtDNA mutation diseases.
- Research is exploring MDP‑based or MDP‑targeted therapies for Alzheimer’s, cognitive decline, macular degeneration, cataracts, and lifespan extension.
Practical Outcomes
- For biohackers, the takeaway is that supporting mitochondrial health may naturally raise humanin levels, potentially offering anti‑aging benefits. While direct humanin supplements are not mainstream, strategies like regular exercise, intermittent fasting, and possibly nutraceuticals that enhance mitochondrial function could be explored. Any supplementation should start low, monitor tolerance, and consider consulting a healthcare professional.
Summary
This paper reviews tiny proteins made by mitochondria, especially humanin, that help protect cells from stress, inflammation, and heart damage, and act like metabolic sensors linked to aging diseases. It suggests that boosting these peptides might help with brain health, eye health, and overall longevity, but it doesn’t give specific dosing or protocols.
Abstract
Mitochondrial-derived peptides (MDPs) are small bioactive peptides encoded by mitochondrial DNA and involved in various stress-protecting mechanisms. To date, eight mitochondrial-derived peptides have been identified: MOTS-c sequence is hidden in the 12 S rRNA gene (MT-RNR1), and the other 7 (humanin and small humanin-like peptides 1-6) are encoded by the 16 S rRNA (MT-RNR2) gene. While the anti-apoptotic, anti-inflammatory and cardioprotective activities of MDPs are well described, recent research suggests that MDPs are sensitive metabolic sensors, closely connected with mtDNA mutation-associated diseases and age-associated metabolic disorders. In this chapter, we focus on the recent progress in understanding the metabolo-protective properties of MDPs, their role in maintenance of the cellular and mitochondrial homeostasis associated with age-related diseases: Alzheimer's disease, cognitive decline, macular degeneration and cataracts. Also, we will discuss MDPs-based and MDPs-targeted interventions to treat age-related diseases and extend a healthy lifespan.
Study Information
pubmed
2023
2023-04-25T00:00:00.000Z
10.1016/bs.apcsb.2023.02.015
3